UBS Maintains Buy on Equifax, Lowers Price Target to $220

Benzinga Newsdesk www.benzinga.com Negative 59.0%

Neg 59% Neu 0% Pos 0%

UBS analyst Kevin Mcveigh maintains Equifax (NYSE:EFX) with a Buy and lowers the price target from $245 to $220.

Comments

No comments yet. Be the first!